{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:47:37Z","timestamp":1770990457439,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ejphar.2014.05.014","type":"journal-article","created":{"date-parts":[[2014,5,22]],"date-time":"2014-05-22T00:50:14Z","timestamp":1400719814000},"page":"194-201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists"],"prefix":"10.1016","volume":"737","author":[{"given":"Ryutaro","family":"Nakashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junko","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narihiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rieko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4292-205X","authenticated-orcid":false,"given":"Shoen","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.05.014_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1463-1326.2011.01525.x","article-title":"GPR40-induced insulin secretion by the novel agonist TAK-875: first clinical findings in patients with type 2 diabetes","volume":"14","author":"Araki","year":"2012","journal-title":"Diab. Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.05.014_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1463-1326.2008.00993.x","article-title":"Fixed-dose single tablet antidiabetic combinations","volume":"11","author":"Bailey","year":"2009","journal-title":"Diab. Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.05.014_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0706770","article-title":"Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules","volume":"148","author":"Briscoe","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(11)61879-5","article-title":"TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"379","author":"Burant","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.014_bib5","doi-asserted-by":"crossref","first-page":"6624","DOI":"10.1021\/jm3002026","article-title":"Free fatty acid receptor 1 (FFA1\/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties","volume":"55","author":"Christiansen","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157488412800958686","article-title":"GLP-1 agonists exenatide and liraglutide: a review about their safety and efficacy","volume":"7","author":"Derosa","year":"2012","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.metabol.2008.10.005","article-title":"Acute administration of GPR40 receptor agonist potentiates glucose-stimulated insulin secretion in vivo in the rat","volume":"58","author":"Doshi","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/j.ejphar.2014.05.014_bib8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2014.05.014_bib9","doi-asserted-by":"crossref","first-page":"45455","DOI":"10.1074\/jbc.M407673200","article-title":"Ca2+-induced Ca2+ release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells","volume":"279","author":"Dyachok","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib10","first-page":"348","article-title":"Carbachol priming increases glucose- and glucagon-like peptide-1 (7-36)amide-, but not arginine-induced insulin secretion from the isolated perfused rat pancreas","volume":"28","author":"Fehmann","year":"1990","journal-title":"Z Gastroenterol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib11","doi-asserted-by":"crossref","first-page":"E670","DOI":"10.1152\/ajpendo.00035.2005","article-title":"Oleic acid interacts with GPR40 to induce Ca2+ signaling in rat islet beta-cells: mediation by PLC and L-type Ca2+ channel and link to insulin release","volume":"289","author":"Fujiwara","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2014.05.014_bib12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-2004-826158","article-title":"On the physiology of GIP and GLP-1","volume":"36","author":"Holst","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2014.05.014_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/361362a0","article-title":"Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)","volume":"361","author":"Holz","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.05.014_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nature01478","article-title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40","volume":"422","author":"Itoh","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2014.05.014_bib15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1463-1326.2009.01194.x","article-title":"Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes","volume":"12","author":"Kaku","year":"2010","journal-title":"Diab. Obes. Metab."},{"key":"10.1016\/j.ejphar.2014.05.014_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/dc12-0872","article-title":"Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes","volume":"36","author":"Kaku","year":"2013","journal-title":"Diab.s Care"},{"key":"10.1016\/j.ejphar.2014.05.014_bib17","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1113\/jphysiol.2005.087510","article-title":"A cAMP and Ca2+ coincidence detector in support of Ca2+-induced Ca2+ release in mouse pancreatic beta cells","volume":"566","author":"Kang","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib18","doi-asserted-by":"crossref","first-page":"31294","DOI":"10.1074\/jbc.M505657200","article-title":"Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line","volume":"280","author":"Landa","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib19","doi-asserted-by":"crossref","first-page":"e27270","DOI":"10.1371\/journal.pone.0027270","article-title":"AMG 837: a novel GPR40\/FFA1 agonist that enhances insulin secretion and lowers glucose levels in rodents","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.05.014_bib20","doi-asserted-by":"crossref","first-page":"e46300","DOI":"10.1371\/journal.pone.0046300","article-title":"A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents","volume":"7","author":"Luo","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2014.05.014_bib21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-2952(02)01482-X","article-title":"Cooperative enhancement of insulinotropic action of GLP-1 by acetylcholine uncovers paradoxical inhibitory effect of beta cell muscarinic receptor activation on adenylate cyclase activity","volume":"65","author":"Miguel","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib22","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1021\/jm300170m","article-title":"Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40\/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent","volume":"55","author":"Negoro","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib23","doi-asserted-by":"crossref","first-page":"11890","DOI":"10.1074\/jbc.C110.200477","article-title":"Conjugated linoleic acids mediate insulin release through islet G protein-coupled receptor FFA1\/GPR40","volume":"286","author":"Schmidt","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib24","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2337\/db08-0130","article-title":"Selective small-molecule agonists of G protein-coupled receptor 40 promote glucose-dependent insulin secretion and reduce blood glucose in mice","volume":"57","author":"Tan","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2014.05.014_bib25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/s00125-006-0193-8","article-title":"Expression of the gene for a membrane-bound fatty acid receptor in the pancreas and islet cell tumours in humans: evidence for GPR40 expression in pancreatic beta cells and implications for insulin secretion","volume":"49","author":"Tomita","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2014.05.014_bib26","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2014.05.014_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1085\/jgp.200409082","article-title":"Protein kinase activation increases insulin secretion by sensitizing the secretory machinery to Ca2+","volume":"124","author":"Wan","year":"2004","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.ejphar.2014.05.014_bib28","doi-asserted-by":"crossref","first-page":"5670","DOI":"10.1074\/jbc.273.10.5670","article-title":"Phosphorylation of inositol 1,4,5-trisphosphate receptors by cAMP-dependent protein kinase. Type I, II, and III receptors are differentially susceptible to phosphorylation and are phosphorylated in intact cells","volume":"273","author":"Wojcikiewicz","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.05.014_bib29","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1085\/jgp.200409081","article-title":"A highly Ca2+-sensitive pool of granules is regulated by glucose and protein kinases in insulin-secreting INS-1 cells","volume":"124","author":"Yang","year":"2004","journal-title":"J. Gen. Physiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914003768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T21:29:38Z","timestamp":1538602178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914003768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"alternative-id":["S0014299914003768"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.014","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}